Advanced Biomed Inc. 8-K/A

What Happened
Advanced Biomed Inc. (ADVB) filed an 8-K (Feb 10, 2026) reporting that on January 30, 2026 it issued 1,650,710 shares of its Common Stock to an Investor as payment for the Investor’s commitment under the parties’ agreement (the “Commitment Fee Shares”). The Company valued the issuance at $500,000 at the time of issuance and states the issuance fulfilled its obligation under the Agreement.

Key Details

• Issuance date: January 30, 2026; 1,650,710 shares of Common Stock issued.
• Aggregate value at issuance: $500,000.
• Issuance made under Section 13.04(b) of the Agreement to the identified “Investor.”
• Securities were issued as unregistered sales relying on the Section 4(a)(2) exemption from registration.

Why It Matters
This filing notifies investors that the company satisfied a contractual commitment by issuing shares rather than cash. The issuance increases the number of outstanding common shares by 1,650,710 and was completed using an exemption from registration, which is common for private placements or contract-based settlements. Investors should note the change in share count and the use of unregistered issuance; the filing does not provide details on total outstanding shares or the Investor’s identity.